CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Enrolment opens for Adaptin Bio’s Phase I trial of glioblastoma therapy

Phase 1APTN-101Positive
AI Analysis

Summary

Adaptin Bio has opened enrollment for a Phase I clinical trial of APTN-101 (BRiTE therapy) in adults with glioblastoma. This is a routine trial initiation announcement.

Clinical Trial Data

Phase

Phase I

Importance:3/10
Sentiment:
0.30
Phase 1glioblastomatrial enrollmentBRiTE therapy
Related Companies

Read the original article

Published by Clinical Trials Arena on August 21, 2026 9:10 AM

Read Original